Selective inhibition of COX-2 improves early survival in murine endotoxemia but not in bacterial peritonitis

Am J Physiol Lung Cell Mol Physiol. 2001 Sep;281(3):L537-43. doi: 10.1152/ajplung.2001.281.3.L537.

Abstract

Prostaglandins of the E series are believed to act as important mediators of several pathophysiological events that occur in sepsis. Studies were performed to evaluate the effect of cyclooxygenase (COX)-2-specific inhibition on the outcome in murine endotoxemia and cecal ligation and puncture (CLP). We observed a significant time-dependent upregulation of PGE(2) production in both blood and lung homogenates of mice administered lipopolysaccharide intraperitoneally, which was nearly completely suppressed by the administration of the COX-2 inhibitor NS-398. Treatment with NS-398 significantly improved early but not late survival in lipopolysaccharide-challenged mice. On the contrary, elevated PGE(2) levels were found in bronchoalveolar lavage fluid but not in plasma of mice subjected to CLP (21 gauge). Pretreatment with NS-398 failed to significantly improve survival in CLP mice. No significant differences were noted in plasma or lung homogenate proinflammatory cytokine levels or lung neutrophil sequestration between the NS-398-treated and control groups. These results demonstrate that selective COX-2 inhibition confers early but not long-term benefits without affecting the expression of proinflammatory cytokines or the development of lung inflammation.

Publication types

  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Animals
  • Bacterial Infections*
  • Body Temperature Regulation / drug effects
  • Cecum
  • Cyclooxygenase 2
  • Cyclooxygenase 2 Inhibitors
  • Cyclooxygenase Inhibitors / therapeutic use*
  • Cytokines / biosynthesis
  • Dinoprostone / antagonists & inhibitors
  • Dinoprostone / biosynthesis
  • Endotoxemia / drug therapy*
  • Endotoxemia / metabolism
  • Endotoxemia / mortality
  • Isoenzymes / antagonists & inhibitors*
  • Ligation
  • Lipopolysaccharides / pharmacology
  • Lung / pathology
  • Mice
  • Mice, Inbred Strains
  • Motor Activity / drug effects
  • Neutrophils / pathology
  • Nitrobenzenes
  • Peritonitis / drug therapy*
  • Peritonitis / metabolism
  • Peritonitis / microbiology*
  • Peritonitis / mortality
  • Prostaglandin-Endoperoxide Synthases
  • Punctures
  • Sulfonamides
  • Survival Analysis

Substances

  • Cyclooxygenase 2 Inhibitors
  • Cyclooxygenase Inhibitors
  • Cytokines
  • Isoenzymes
  • Lipopolysaccharides
  • Nitrobenzenes
  • Sulfonamides
  • N-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide
  • Cyclooxygenase 2
  • Prostaglandin-Endoperoxide Synthases
  • Dinoprostone